Submitted by Anonymous (not verified) on 9 July 2026 - 11:30
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised